ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693185 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693185; 2) Community: the network communities that were significantly associated with the response to NSC 693185; 3) Molecule: the relationships between components within communities and NSC 693185; 4) MDR: the compounds that were significantly associated with the NSC 693185.

NSC Compound Enrichment Correlation
NSC 670313 Null 0.0489393809599837 0.17211952
NSC 671392 Null 0.0489393809599837 0.2797841
NSC 673186 Null 0.0489393809599837 0.20693455
NSC 677598 Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer 0.0489393809599837 0.048868933
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.0489393809599837 0.28738613
NSC 67925 Null 0.0489393809599837 0.098075131
NSC 681239 Bortezomib 0.0489393809599837 0.3477194
NSC 681968 Benzoic acid, [[2-methyl-4-[bis(2-cyanoethyl)amino]phenyl]methylene] hydrazide 0.0489393809599837 0.14878134
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0489393809599837 0.33059551
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0489393809599837 -0.063640323
Total:96  Current:95    [First] [Prev] [Next] [Last]